Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer to strengthen global commercial strategy
Mar 3, 2026
Industry News
Lucy Foley appointed to BioPhorum Strategic Advisory Board
Feb 6, 2026
Industry News
Efficiency, Scale and the Role of Cohesive CMC and Manufacturing Planning
Dec 9, 2025
Blog
eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies
Dec 2, 2025
Industry News
eXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway
Nov 26, 2025
Industry News
eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading CGT services in Southeast Asia
Sep 23, 2025
Industry News
eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services to offer end-to-end support for cell therapy developers
Sep 2, 2025
Industry News
Rethinking iPSC Development: Why Adopting an Early CMC Strategy is Essential
Aug 13, 2025
Start with the End in Mind: Materials Control in Early CMC Strategy
Jul 31, 2025